Cancer Gene Therapy Market by Key Manufacturers, By Type (Oncolytic Virotherapy, Gene Transfer, Gene-Induced Immunotherapy), By Application (Hospitals, Diagnostics Centers, Research Institutes) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Report ID: 391528 | Apr 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Cancer Gene Therapy Market size is estimated to record USD 7267.89 Million by 2026, at a Compound Annual Growth Rate (CAGR) of 33.5 %.
Cancer Gene Therapy Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 961.70 Million in 2019.
The market report includes Cancer Gene Therapy market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which include drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Thermal Screening Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends include core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Thermal Screening Market Competitive Landscape
The key companies in Cancer Gene Therapy Market are Adaptimmune, Bluebird bio, , Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, ynerGene Therapeutics, Altor BioScience, Amgen, Argenx, BioCancell, GlaxoSmithKline, Merck.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Cancer Gene Therapy Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 961.70 Million in 2019.
The market report includes Cancer Gene Therapy market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which include drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Thermal Screening Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends include core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Thermal Screening Market Competitive Landscape
The key companies in Cancer Gene Therapy Market are Adaptimmune, Bluebird bio, , Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, ynerGene Therapeutics, Altor BioScience, Amgen, Argenx, BioCancell, GlaxoSmithKline, Merck.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Cancer Gene Therapy Industry, By Type
5.1. Cancer Gene Therapy Market, By Type 2019-2026
5.2. Oncolytic Virotherapy
5.3. Gene Transfer
5.4. Gene-Induced Immunotherapy
Chapter 6. Cancer Gene Therapy Industry, By Applications
6.1. Cancer Gene Therapy Market, By Applications 2019-2026
6.2. Hospitals
6.3. Diagnostics Centers
6.4. Research Institutes
Chapter 7. Cancer Gene Therapy Market, By Region
7.1. Cancer Gene Therapy Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.1.3. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Adaptimmune
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Bluebird bio
9.3. Celgene
9.4. Shanghai Sunway Biotech
9.5. Shenzhen SiBiono GeneTech
9.6. SynerGene Therapeutics
9.7. Altor BioScience
9.8. Amgen
9.9. Argenx
9.10. BioCancell
9.11. GlaxoSmithKline
9.12. Merck
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Cancer Gene Therapy Industry, By Type
5.1. Cancer Gene Therapy Market, By Type 2019-2026
5.2. Oncolytic Virotherapy
5.3. Gene Transfer
5.4. Gene-Induced Immunotherapy
Chapter 6. Cancer Gene Therapy Industry, By Applications
6.1. Cancer Gene Therapy Market, By Applications 2019-2026
6.2. Hospitals
6.3. Diagnostics Centers
6.4. Research Institutes
Chapter 7. Cancer Gene Therapy Market, By Region
7.1. Cancer Gene Therapy Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.1.3. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Adaptimmune
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Bluebird bio
9.3. Celgene
9.4. Shanghai Sunway Biotech
9.5. Shenzhen SiBiono GeneTech
9.6. SynerGene Therapeutics
9.7. Altor BioScience
9.8. Amgen
9.9. Argenx
9.10. BioCancell
9.11. GlaxoSmithKline
9.12. Merck
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1. Adaptimmune
2. Bluebird bio
3. Celgene
4. Shanghai Sunway Biotech
5. Shenzhen SiBiono GeneTech
6. SynerGene Therapeutics
7. Altor BioScience
8. Amgen
9. Argenx
10. BioCancell
11. GlaxoSmithKline
12. Merck
2. Bluebird bio
3. Celgene
4. Shanghai Sunway Biotech
5. Shenzhen SiBiono GeneTech
6. SynerGene Therapeutics
7. Altor BioScience
8. Amgen
9. Argenx
10. BioCancell
11. GlaxoSmithKline
12. Merck
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
(COVID Version) Global Cotton Buds Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 105
|
$3000Buy Now |
|
|
(COVID Version) Global Cotton Balls and Swabs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 110
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Surgery Equipment Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 108
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Prostheses Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 100
|
$3000Buy Now |
|
|
(COVID Version) Global Cortisone Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 103
|
$3000Buy Now |